INHIBRX BIOSCIENCES INC
INBXNASDAQ🏆 #2120 by market capEarnings Aug 12US Equity
$96.47▲ $4.27 (+4.43%)
Live1h▲ 0.1%
24h▲ 4.4%
7d▲ 14.7%
14d▲ 21.5%
30d▲ 4.4%
1y▲ 352.6%
🏦Market Cap
$1.42B
Small Cap
📈Revenue Growth (YoY)
+550.0%
High Growth
📊Gross Margin
-80.4%
Thin
💵FCF Margin
-10148.9%
Thin
⚖️P/S Ratio
1042.6x
Expensive
Otter Score
65
Fair
Earnings
Q2 · 2026Reported 2026-05-14Earnings Per Share
Actual
-2.15
Expected
-2.37
beat
+9.30%
YoY +23.20%
Revenue
Actual
—
Expected
—
—
—
Consensus estimates
Recent quarters
Q2 2026
-2.15
beat
Q1 2026
-2.11
miss
Q4 2025
-2.28
miss
Q3 2025
-1.85
beat